Effects of valsartan on osteoprotegerin and receptor activator of nuclear factor kappa B ligand levels in patients with type 2 diabetes, systolic hypertension and microalbuminuria

Research output: Contribution to journalConference paperpeer-review

Original languageEnglish
Pages (from-to)S444-S444
Number of pages1
Publication statusPublished - Sept 2011
Event47th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Lisbon, Portugal
Duration: 12 Sept 201116 Sept 2011

Cite this